Literature DB >> 14501219

AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration.

Judith Stegmüller1, Stephanie Schneider, Andrea Hellwig, Jeremy Garwood, Jacqueline Trotter.   

Abstract

Molecular studies have demonstrated that the murine AN2 antigen is the mouse homologue of the rat NG2 and human MCSP protein. The molecule is a single-pass transmembrane protein which carries a variable number of glyco- and glycosaminoglycan chains according to cell type and developmental stage. AN2/NG2 has two extracellular Laminin G-like domains which are classically involved in cell adhesion and recognition. It possesses a single PDZ binding motif in the short intracellular tail. The AN2/NG2 antigen is expressed by glial progenitor cells in developing and adult CNS and also by immature Schwann cells. Antibodies against AN2/NG2 inhibit the migration of antigen-positive cells in in vitro assays, suggesting that the molecule plays a role in migration. Many AN2/NG2-positive cells surround synapses in the developing and adult brain. A recently identified intracellular partner of AN2/NG2 is the glutamate receptor interacting protein GRIP, which binds to the GluRB subunit of the AMPA subclass of glutamate receptors. The AN2/NG2 protein may position AMPA receptors on perisynaptic glial cells towards active synapses by binding to a neuronal receptor. Many highly migratory neural tumors including melanomas express AN2/NG2. In the demyelinating disease Multiple Sclerosis, some patients synthesise antibodies against the protein. Such antibodies may play a pathological role by inhibiting the migration of oligodendrocyte progenitor cells to demyelinated axons thus blocking remyelination, as well as possibly interfering with glial neuronal signalling at synapses and nodes of Ranvier.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14501219     DOI: 10.1023/a:1025743731306

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  22 in total

Review 1.  CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Authors:  Matthew A Price; Leah E Colvin Wanshura; Jianbo Yang; Jennifer Carlson; Bo Xiang; Guiyuan Li; Soldano Ferrone; Arkadiusz Z Dudek; Eva A Turley; James B McCarthy
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

2.  Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.

Authors:  Tanja Kuhlmann; Leah Remington; Isabelle Cognet; Lyne Bourbonniere; Simone Zehntner; Florence Guilhot; Alexandra Herman; Angélique Guay-Giroux; Jack P Antel; Trevor Owens; Jean-François Gauchat
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.

Authors:  Jordan Darden; Laura Beth Payne; Huaning Zhao; John C Chappell
Journal:  Angiogenesis       Date:  2018-09-20       Impact factor: 9.596

4.  Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin.

Authors:  Berit E Powers; Drew L Sellers; Emilie A Lovelett; Willy Cheung; Sheida P Aalami; Nikolai Zapertov; Don O Maris; Philip J Horner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  Development of NG2 neural progenitor cells requires Olig gene function.

Authors:  Keith L Ligon; Santosh Kesari; Masaaki Kitada; Tao Sun; Heather A Arnett; John A Alberta; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 6.  Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.

Authors:  Fabien Binamé
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

7.  The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.

Authors:  Ian Smyth; Xin Du; Martin S Taylor; Monica J Justice; Bruce Beutler; Ian J Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-02       Impact factor: 11.205

Review 8.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

9.  Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.

Authors:  Jianbo Yang; Matthew A Price; Gui Yuan Li; Menashe Bar-Eli; Ravi Salgia; Ramasamy Jagedeeswaran; Jennifer H Carlson; Soldano Ferrone; Eva A Turley; James B McCarthy
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

Review 10.  NG2 cells: Properties, progeny and origin.

Authors:  Jacqueline Trotter; Khalad Karram; Akiko Nishiyama
Journal:  Brain Res Rev       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.